Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
Authors
Ferran Nadeu,
Julio DelgadoCristina Royo,
Tycho Baumann,
Tatjana Stanković,
Magda Pinyol,
Pedro Jares,
Alba Navarro,
David Martin‐García,
Sı́lvia Beà,
Itziar Salaverría,
Ceri Oldreive,
Marta Aymerich,
Helena Suárez-Cisneros,
Marı́a Rozman,
Neus Villamor,
Dolors Colomer,
Armando López‐Guillermo,
Marcos González,
Miguel Alcoceba,
María Terol,
Enrique Colado,
Xosé Puente,
Carlos López‐Otín,
Anna Enjuanes,
Elı́as Campo,
Tatjana Stankovic +25 authors
,
Douglas Easton Tip Tip